Patents Assigned to SESEN BIO, INC.
  • IL-6 antagonists and uses thereof
    Patent number: 11459386
    Abstract: Interleukin-6 (IL-6) antagonists are provided that are specific for binding to site II of IL-6. Methods of using such inhibitors to treat IL-6 related diseases, e.g., disease of the eye such as diabetic macular edema are disclosed.
    Type: Grant
    Filed: January 26, 2018
    Date of Patent: October 4, 2022
    Assignee: Sesen Bio, Inc.
    Inventors: Michael March Schmidt, Thomas M. Barnes, David V. Erbe, Eric Steven Furfine, Alison Tisdale
  • IL-6 antibodies
    Patent number: 11142571
    Abstract: Improved IL-6 antibodies are provided. Uses of the antibodies in the treatment of IL-6-related diseases, e.g., ocular diseases such as diabetic macular edema, are disclosed.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: October 12, 2021
    Assignee: SESEN BIO, INC.
    Inventors: Michael March Schmidt, Alison Tisdale, Eric Steven Furfine, Grigorios Zarbis-Papastoitsis
  • IL-6 antibodies
    Patent number: 10947309
    Abstract: Improved IL-6 antibodies are provided. Uses of the antibodies in the treatment of IL-6-related diseases, e.g., ocular diseases such as diabetic macular edema, are disclosed.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: March 16, 2021
    Assignee: SESEN BIO, INC.
    Inventors: Michael March Schmidt, Alison Tisdale, Eric Steven Furfine, Grigorios Zarbis-Papastoitsis